{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:49:11Z","timestamp":1791992951244,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00415-025-13168-z","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T01:34:34Z","timestamp":1750037674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is intravenous aciclovir overused in possible viral encephalitis? a retrospective review"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7811-0471","authenticated-orcid":false,"given":"Anna","family":"Wakelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-4551","authenticated-orcid":false,"given":"Anthony","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-3848","authenticated-orcid":false,"given":"Heather","family":"Angus-Leppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"13168_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92623-0","author":"B Sk\u00f6ldenberg","year":"1984","unstructured":"Sk\u00f6ldenberg B et al (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(84)92623-0","journal-title":"Lancet"},{"key":"13168_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601163140303","author":"RJ Whitley","year":"1986","unstructured":"Whitley RJ et al (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJM198601163140303","journal-title":"N Engl J Med"},{"key":"13168_CR3","unstructured":"National Institute for Health and Care Excellence (2024). Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management, NICE, London. https:\/\/www.nice.org.uk\/guidance\/ng240. Accessed 09 Jan 2025"},{"key":"13168_CR4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1909.130064","author":"J Granerod","year":"2013","unstructured":"Granerod J, Cousens S, Davies NWS, Crowcroft NS (2013) Thomas new estimates of incidence of encephalitis in England. Emerg Infect Dis. https:\/\/doi.org\/10.3201\/eid1909.130064","journal-title":"Emerg Infect Dis"},{"key":"13168_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.04.002","author":"RJ Whitley","year":"2006","unstructured":"Whitley RJ (2006) Herpes simplex encephalitis: adolescents and adults. Antiviral Res. https:\/\/doi.org\/10.1016\/j.antiviral.2006.04.002","journal-title":"Antiviral Res"},{"key":"13168_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70222-X","author":"J Granerod","year":"2010","unstructured":"Granerod J et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study\u2019. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(10)70222-X","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"13168_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon T et al (2012) Management of suspected viral encephalitis in adults \u2013 association of british neurologists and british infection association national guidelines\u2019. J Infect 64(4):347\u2013373. https:\/\/doi.org\/10.1016\/j.jinf.2011.11.014","journal-title":"J Infect"},{"key":"13168_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1130090","author":"LS Abbuehl","year":"2023","unstructured":"Abbuehl LS, Hofmann E, Hakim A, Dietmann A (2023) Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis. A narrative review. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1130090","journal-title":"Front Neurol"},{"key":"13168_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100747","volume":"35","author":"RA Evans","year":"2023","unstructured":"Evans RA et al (2023) Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. Lancet Region Health 35:100747. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100747","journal-title":"Lancet Region Health"},{"issue":"8","key":"13168_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A et al (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis Consortium\u2019. Clin Infect Dis 57(8):1114\u20131128. https:\/\/doi.org\/10.1093\/cid\/cit458","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13168_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1017\/S0950268810000725","volume":"138","author":"J Granerod","year":"2010","unstructured":"Granerod J et al (2010) Causality in acute encephalitis: defining aetiologies\u2019. Epidemiol Infect 138(6):783\u2013800. https:\/\/doi.org\/10.1017\/S0950268810000725","journal-title":"Epidemiol Infect"},{"issue":"5","key":"13168_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1468-1331.2005.01126.x","volume":"12","author":"I Steiner","year":"2005","unstructured":"Steiner I et al (2005) Viral encephalitis: a review of diagnostic methods and guidelines for management. Euro J of Neurology 12(5):331\u2013343. https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01126.x","journal-title":"Euro J of Neurology"},{"key":"13168_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.4.339","author":"P Cinque","year":"1996","unstructured":"Cinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, Van Loon AM (1996) The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report .The EU concerted action on virus meningitis and encephalitis. J Neurol Neurosurg Psychiat. https:\/\/doi.org\/10.1136\/jnnp.61.4.339","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"13168_CR14","doi-asserted-by":"publisher","DOI":"10.1086\/339550","author":"AA Weil","year":"2002","unstructured":"Weil AA, Glaser CA, Amad Z, Forghani B (2002) Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. https:\/\/doi.org\/10.1086\/339550","journal-title":"Clin Infect Dis"},{"issue":"3","key":"13168_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","volume":"47","author":"AR Tunkel","year":"2008","unstructured":"Tunkel AR et al (2008) The management of encephalitis: clinical practice guidelines by the infectious diseases society of America\u2019. Clin Infect Dis 47(3):303\u2013327. https:\/\/doi.org\/10.1086\/589747","journal-title":"Clin Infect Dis"},{"issue":"5","key":"13168_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/cid\/ciad456","volume":"77","author":"KC Bloch","year":"2023","unstructured":"Bloch KC, Glaser C, Gaston D (2023) Executive summary: state-of-the art: acute encephalitis. Clin Infect Dis 77(5):669\u2013671. https:\/\/doi.org\/10.1093\/cid\/ciad456","journal-title":"Clin Infect Dis"},{"key":"13168_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.884","author":"D Assefa","year":"2016","unstructured":"Assefa D, Grinberg S, Achu E, Nagarakanti S, Bishburg E (2016) Empiric acyclovir use for suspected herpes simplex meningoencephalitis: how are we doing. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofw172.884","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"13168_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.7861\/clinmedicine.9-3-231","volume":"9","author":"DJ Bell","year":"2009","unstructured":"Bell DJ et al (2009) Management of suspected herpes simplex virus encephalitis in adults in a UK teaching hospital. Clin Med 9(3):231\u2013235. https:\/\/doi.org\/10.7861\/clinmedicine.9-3-231","journal-title":"Clin Med"},{"issue":"10","key":"13168_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/qjmed\/hcq121","volume":"103","author":"BD Michael","year":"2010","unstructured":"Michael BD et al (2010) Acute central nervous system infections in adults\u2013a retrospective cohort study in the NHS North West region. QJM 103(10):749\u2013758. https:\/\/doi.org\/10.1093\/qjmed\/hcq121","journal-title":"QJM"},{"issue":"2","key":"13168_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40265-013-0007-5","volume":"73","author":"M Studahl","year":"2013","unstructured":"Studahl M et al (2013) Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs 73(2):131\u2013158. https:\/\/doi.org\/10.1007\/s40265-013-0007-5","journal-title":"Drugs"},{"key":"13168_CR21","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-155","author":"M Ellul","year":"2018","unstructured":"Ellul M, Solomon T (2018) Acute encephalitis\u2013diagnosis and management. Clin Med. https:\/\/doi.org\/10.7861\/clinmedicine.18-2-155","journal-title":"Clin Med"},{"issue":"4","key":"13168_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","volume":"72","author":"F McGill","year":"2016","unstructured":"McGill F et al (2016) The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 72(4):405\u2013438. https:\/\/doi.org\/10.1016\/j.jinf.2016.01.007","journal-title":"J Infect"},{"key":"13168_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.3.321","author":"N McGrath","year":"1997","unstructured":"McGrath N, Anderson NE, Croxson MC, Powell KF (1997) Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatr. https:\/\/doi.org\/10.1136\/jnnp.63.3.321","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"13168_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1086\/341405","volume":"35","author":"F Raschilas","year":"2002","unstructured":"Raschilas F et al (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 35(3):254\u2013260. https:\/\/doi.org\/10.1086\/341405","journal-title":"Clin Infect Dis"},{"key":"13168_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.129098","author":"T Solomon","year":"2007","unstructured":"Solomon T, Hart IJ, Beeching NJ (2007) Viral encephalitis: a clinician\u2019s guide. Pract Neurol. https:\/\/doi.org\/10.1136\/jnnp.2007.129098","journal-title":"Pract Neurol"},{"issue":"6","key":"13168_CR26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1469-0691.2009.02735.x","volume":"15","author":"J Poissy","year":"2009","unstructured":"Poissy J et al (2009) Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis\u2019. Clin Microbiol Infect 15(6):560\u2013564. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02735.x","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"13168_CR27","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1128\/AAC.05016-14","volume":"59","author":"H Erdem","year":"2015","unstructured":"Erdem H et al (2015) Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis. Antimicrob Agents Chemother 59(6):3084\u20133089. https:\/\/doi.org\/10.1128\/AAC.05016-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"13168_CR28","doi-asserted-by":"publisher","first-page":"568.e9","DOI":"10.1016\/j.cmi.2016.03.027","volume":"22","author":"Y Cag","year":"2016","unstructured":"Cag Y et al (2016) Managing atypical and typical herpetic central nervous system infections: results of a multinational study. Clin Microbiol Infect 22(6):568.e9-568.e17. https:\/\/doi.org\/10.1016\/j.cmi.2016.03.027","journal-title":"Clin Microbiol Infect"},{"key":"13168_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2005.07.019","author":"PC Benson","year":"2006","unstructured":"Benson PC, Swadron SP (2006) Empiric acyclovir is infrequently initiated in the emergency department to patients ultimately diagnosed with encephalitis. Ann Emerg Med. https:\/\/doi.org\/10.1016\/j.annemergmed.2005.07.019","journal-title":"Ann Emerg Med"},{"key":"13168_CR30","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2022-0031","author":"JM Kim","year":"2023","unstructured":"Kim JM, Nishi C, Grant JM (2023) A retrospective review of empiric acyclovir prescribing practices for suspected viral central nervous system infections: a single-centre study. J Associat Med Microbiol InfectDis Canada. https:\/\/doi.org\/10.3138\/jammi-2022-0031","journal-title":"J Associat Med Microbiol InfectDis Canada"},{"issue":"1","key":"13168_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0002-9343(82)90087-0","volume":"73","author":"D Brigden","year":"1982","unstructured":"Brigden D, Rosling AE, Woods NC (1982) Renal function after acyclovir intravenous injection. American J M 73(1):182\u2013185. https:\/\/doi.org\/10.1016\/0002-9343(82)90087-0","journal-title":"American J M"},{"issue":"6","key":"13168_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/0002-9343(88)90313-0","volume":"84","author":"MH Sawyer","year":"1988","unstructured":"Sawyer MH, Webb DE, Balow JE, Straus SE (1988) Acyclovir-induced renal failure. Amer J Med 84(6):1067\u20131071. https:\/\/doi.org\/10.1016\/0002-9343(88)90313-0","journal-title":"Amer J Med"},{"issue":"5","key":"13168_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1590\/S0104-42302005000500019","volume":"51","author":"LR Pacheco","year":"2005","unstructured":"Pacheco LR et al (2005) Insufici\u00eancia renal aguda associada ao uso de aciclovir endovenoso\u2019. Rev Assoc Med Bras 51(5):275\u2013278. https:\/\/doi.org\/10.1590\/S0104-42302005000500019","journal-title":"Rev Assoc Med Bras"},{"key":"13168_CR34","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v69i1.1517","author":"L Dubrofsky","year":"2016","unstructured":"Dubrofsky L, Kerzner RS, Delaunay C, Kolenda C, Pepin J, Schwartz BC (2016) Interdisciplinary systems-based intervention to improve IV hydration during parenteral administration of acyclovir. CJHP. https:\/\/doi.org\/10.4212\/cjhp.v69i1.1517","journal-title":"CJHP"},{"issue":"1","key":"13168_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/0886022X.2018.1487866","volume":"40","author":"EJ Lee","year":"2018","unstructured":"Lee EJ et al (2018) The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration\u2019. Ren Fail 40(1):687\u2013692. https:\/\/doi.org\/10.1080\/0886022X.2018.1487866","journal-title":"Ren Fail"},{"issue":"10","key":"13168_CR36","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10096-018-3332-5","volume":"37","author":"RKB Richelsen","year":"2018","unstructured":"Richelsen RKB, Jensen SB, Nielsen H (2018) Incidence and predictors of intravenous acyclovir-induced nephrotoxicity. Eur J Clin Microbiol Infect Dis 37(10):1965\u20131971. https:\/\/doi.org\/10.1007\/s10096-018-3332-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13168_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.07.002","author":"L Ryan","year":"2018","unstructured":"Ryan L, Heed A, Foster J, Valappil M, Schmid ML, Duncan CJA (2018) Acute kidney injury (AKI) associated with intravenous aciclovir in adults: Incidence and risk factors in clinical practice. Intern J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2018.07.002","journal-title":"Intern J Infect Dis"},{"key":"13168_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz121","author":"KE Barber","year":"2019","unstructured":"Barber KE, Wagner JL, Stover KR (2019) Impact of obesity on acyclovir-induced nephrotoxicity. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofz121","journal-title":"Open Forum Infect Dis"},{"key":"13168_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.03.013","author":"AM Al-Alawi","year":"2022","unstructured":"Al-Alawi AM, Al-Maqbali JS, Al-Adawi M, Al-Jabri A, Falhammar H (2022) Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity. Saudi Pharmaceut J. https:\/\/doi.org\/10.1016\/j.jsps.2022.03.013","journal-title":"Saudi Pharmaceut J"},{"issue":"6","key":"13168_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/ndt\/gfg119","volume":"18","author":"A Hellden","year":"2003","unstructured":"Hellden A et al (2003) High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study\u2019. Nephrol Dial Transplant 18(6):1135\u20131141. https:\/\/doi.org\/10.1093\/ndt\/gfg119","journal-title":"Nephrol Dial Transplant"},{"key":"13168_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12520","author":"WA Watson","year":"2017","unstructured":"Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH (2017) Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: a case report and review of the literature. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.12520","journal-title":"J Clin Pharm Ther"},{"key":"13168_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13464","author":"D Brandariz-Nu\u00f1ez","year":"2021","unstructured":"Brandariz-Nu\u00f1ez D, Correas-Sanahuja M, Maya-Gallego S, Mart\u00edn Herranz I (2021) Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases\u2019. J Clin Pharm Ther. https:\/\/doi.org\/10.1111\/jcpt.13464","journal-title":"J Clin Pharm Ther"},{"key":"13168_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2022-003597","author":"FW Vonberg","year":"2023","unstructured":"Vonberg FW, Dawson A, Scott G, Davies N (2023) Aciclovir-induced neurotoxicity. Pract Neurol. https:\/\/doi.org\/10.1136\/pn-2022-003597","journal-title":"Pract Neurol"},{"key":"13168_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2019.03.050","author":"J Patel","year":"2019","unstructured":"Patel J, Hayes B, Bauler L, Mastenbrook J (2019) Neurologic acyclovir toxicity in the absence of kidney injury. J Emerg Med. https:\/\/doi.org\/10.1016\/j.jemermed.2019.03.050","journal-title":"J Emerg Med"},{"key":"13168_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.385","author":"S Feldman","year":"1988","unstructured":"Feldman S, Rodman J, Gregory B (1988) Excessive serum concentrations of acyclovir and neurotoxicity. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/157.2.385","journal-title":"J Infect Dis"},{"key":"13168_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.03.001","author":"JL Gentry","year":"2015","unstructured":"Gentry JL, Peterson C (2015) Death delusions and myoclonus: acyclovir toxicity. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2015.03.001","journal-title":"Am J Med"},{"key":"13168_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3489","author":"GE Thwaites","year":"2012","unstructured":"Thwaites GE (2012) The management of suspected encephalitis. BMJ. https:\/\/doi.org\/10.1136\/bmj.e3489","journal-title":"BMJ"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13168-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T06:26:06Z","timestamp":1752301566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13168-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["13168"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13168-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved on 14\/02\/2024 by the Royal Free Clinical Governance Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"463"}}